Paper39476205
miR-128-3p suppresses tumor growth and enhances chemosensitivity in tongue squamous cell carcinoma through MAP2K7 targeting.
Gupta P and 1 other. Mol Biol Rep, 2024. Cited by 6 papers, by iCite.
Cite this record
ConductScience Library. miR-128-3p suppresses tumor growth and enhances chemosensitivity in tongue squamous cell carcinoma through MAP2K7 targeting. Papers, record 39476205. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39476205
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- miR-128-3p suppresses tumor growth and enhances chemosensitivity in tongue squamous cell carcinoma through MAP2K7 targeting.
- PubMed
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| MicroRNAs | Major topic |
| Tongue Neoplasms | Major topic |
| Cell Proliferation | Major topic |
| Gene Expression Regulation, Neoplastic | Major topic |
| Epithelial-Mesenchymal Transition | Major topic |
| Drug Resistance, Neoplasm | Major topic |
| Cisplatin | Major topic |
| Cell Movement | Major topic |
| Carcinoma, Squamous Cell | Major topic |
| Humans | |
| Cell Line, Tumor | |
| Animals | |
| MAP Kinase Kinase Kinases | |
| MAP Kinase Signaling System | |
| Apoptosis | |
| Mice | |
| MAP Kinase Kinase Kinase 7 |
Source PubMed
References71
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 36688618 | Integrative analysis of small non-coding RNAs predicts a piRNA/miRNA-CCND1/BRAF/HRH1/ATXN3 regulatory circuit that drives oncogenesis in glioblastoma. | Mol Omics | 2023 | https://conductscience.org/library/papers/36688618 | PubMed |
| 2 | 32650236 | Cell Type Impacts Accessibility of mRNA to Silencing by RNA Interference. | Mol Ther Nucleic Acids | 2020 | https://conductscience.org/library/papers/32650236 | PubMed |
| 3 | 33991762 | MiR-128-3p suppresses tumor proliferation and metastasis via targeting CDC6 in hepatocellular carcinoma cells. | Tissue Cell | 2021 | https://conductscience.org/library/papers/33991762 | PubMed |
| 4 | 31918270 | MiR-155-5p promotes oral cancer progression by targeting chromatin remodeling gene ARID2. | Biomed Pharmacother | 2020 | https://conductscience.org/library/papers/31918270 | PubMed |
| 5 | 31639019 | The Jun N-terminal kinases signaling pathway plays a "seesaw" role in ovarian carcinoma: a molecular aspect. | J Ovarian Res | 2019 | https://conductscience.org/library/papers/31639019 | PubMed |
| 6 | 33796026 | Insight Into the Prospects for RNAi Therapy of Cancer. | Front Pharmacol | 2021 | https://conductscience.org/library/papers/33796026 | PubMed |
| 7 | 22870247 | Increased JNK1 signaling pathway is responsible for ABCG2-mediated multidrug resistance in human colon cancer. | PLoS One | 2012 | https://conductscience.org/library/papers/22870247 | PubMed |
| 8 | 28260044 | microRNA-125b reverses the multidrug resistance of nasopharyngeal carcinoma cells via targeting of Bcl-2. | Mol Med Rep | 2017 | https://conductscience.org/library/papers/28260044 | PubMed |
| 9 | 37215991 | Inhibition of JNK/c-Jun-ATF2 Overcomes Cisplatin Resistance in Liver Cancer through down-Regulating Galectin-1. | Int J Biol Sci | 2023 | https://conductscience.org/library/papers/37215991 | PubMed |
| 10 | 36255066 | miRNome-transcriptome analysis unveils the key regulatory pathways involved in the tumorigenesis of tongue squamous cell carcinoma. | Brief Funct Genomics | 2022 | https://conductscience.org/library/papers/36255066 | PubMed |
| 11 | 25791601 | Dual luciferase gene reporter assays to study miRNA function. | Methods Mol Biol | 2015 | https://conductscience.org/library/papers/25791601 | PubMed |
| 12 | 30277613 | MiR-125b suppresses the carcinogenesis of osteosarcoma cells via the MAPK-STAT3 pathway. | J Cell Biochem | 2019 | https://conductscience.org/library/papers/30277613 | PubMed |
| 13 | 29516950 | Mechanisms correlated with chemotherapy resistance in tongue cancers. | J Cancer Res Ther | 2018 | https://conductscience.org/library/papers/29516950 | PubMed |
| 14 | 31579105 | MKK7, the essential regulator of JNK signaling involved in cancer cell survival: a newly emerging anticancer therapeutic target. | Ther Adv Med Oncol | 2019 | https://conductscience.org/library/papers/31579105 | PubMed |
| 15 | 37473805 | FDFT1 repression by piR-39980 prevents oncogenesis by regulating proliferation and apoptosis through hypoxia in tongue squamous cell carcinoma. | Life Sci | 2023 | https://conductscience.org/library/papers/37473805 | PubMed |
| 16 | 34645978 | A highly annotated database of genes associated with platinum resistance in cancer. | Oncogene | 2021 | https://conductscience.org/library/papers/34645978 | PubMed |
| 17 | 31078043 | MiR-128-3p suppresses breast cancer cellular progression via targeting LIMK1. | Biomed Pharmacother | 2019 | https://conductscience.org/library/papers/31078043 | PubMed |
| 18 | 22796517 | Subcellular targets of cisplatin cytotoxicity: an integrated view. | Pharmacol Ther | 2012 | https://conductscience.org/library/papers/22796517 | PubMed |
| 19 | 32334405 | Epithelial-Mesenchymal Transition in Cancer: A Historical Overview. | Transl Oncol | 2020 | https://conductscience.org/library/papers/32334405 | PubMed |
| 20 | 28351566 | MicroRNAs in human tongue squamous cell carcinoma: From pathogenesis to therapeutic implications. | Oral Oncol | 2017 | https://conductscience.org/library/papers/28351566 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42436998 | Chlorotoxin suppresses melanoma vasculogenic mimicry via LINC01235/miR-128-3p/YY1/ VEGFR2/NRP1 axis. | iScience | 2026 | https://conductscience.org/library/papers/42436998 | PubMed |
| 39982595 | The impact of the ATP-binding cassette (ABC) transporter family on multidrug resistance in head and neck tumors. | Mol Biol Rep | 2025 | https://conductscience.org/library/papers/39982595 | PubMed |
| 39808313 | MiRNAs: main players of cancer drug resistance target ABC transporters. | Naunyn Schmiedebergs Arch Pharmacol | 2025 | https://conductscience.org/library/papers/39808313 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| JUN | 3725 | PubTator's text mining | https://conductscience.org/library/genes/3725 | NCBI Gene |
| MAP2K7 | 5609 | PubTator's text mining | https://conductscience.org/library/genes/5609 | NCBI Gene |
| MAPK8 | 5599 | PubTator's text mining | https://conductscience.org/library/genes/5599 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39476205
GET https://conductscience.org/api/papers/v1/39476205/references?page=2